Onsior
robenacoxib
Table of contents
Overview
Onsior is an anti-inflammatory veterinary medicine for use in cats and dogs to treat pain and inflammation.
In cats, Onsior tablets are used to treat pain and inflammation associated with acute (short term) and chronic (long term) musculoskeletal disorders (problems with the muscles and bones) and to reduce moderate pain and inflammation associated with orthopaedic (bone) surgery. The solution for injection is used to treat pain and inflammation associated with orthopaedic or soft tissue surgery, such as neutering.
In dogs, Onsior tablets are used to treat pain and inflammation associated with chronic osteoarthritis (a long-term disease causing pain and inflammation in the joints) and soft tissue surgery. The solution for injection is used to treat pain and inflammation associated with orthopaedic or soft tissue surgery.
Onsior contains the active substance robenacoxib.
Authorisation details
Product details | |
---|---|
Name |
Onsior
|
Agency product number |
EMEA/V/C/000127
|
Active substance |
robenacoxib
|
International non-proprietary name (INN) or common name |
robenacoxib
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QM01AH91
|
Publication details | |
---|---|
Marketing-authorisation holder |
Elanco GmbH
|
Revision |
14
|
Date of issue of marketing authorisation valid throughout the European Union |
16/12/2008
|
Contact address |
Heinz-Lohmann-Str 4 |
Product information
06/01/2021 Onsior - EMEA/V/C/000127 - IB/0029
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Anti-inflammatory and anti-rheumatic products, non-steroids
-
Coxibs
Therapeutic indication
Cats (tablets):
For the treatmentRelief of pain and inflammation associated with acute andor chronic musculo-skeletal disorders.
For the reduction of moderate pain and inflammation associated with orthopaedic surgery.
Dogs (tablets):
For the Ttreatment of pain and inflammation associated with chronic osteoarthritis.
For the treatment of pain and inflammation associated with soft tissue surgery.
Cats and dogs (solution for injection):
For the Ttreatment of pain and inflammation associated with orthopaedic or soft tissue surgery.